OBJECTIVE: This study was to evaluate the efficacy of percutaneous vertebroplasty (PVP) in treating vertebral metastases, focusing on the related intractable @entity158 and operative complications including cement leakage, @entity409 , dysneuria, etc. @entity1 AND METHODS: Forty-seven @entity1 with spinal @entity5 who underwent PVP between September 2011 and March 2013 in the hospital were evaluated retrospectively. @entity158 scores on one day before the surgery, on one day after the surgery and at the end of the follow-up were recorded using VAS. The VAS scores were analyzed by Wilcoxon rank-sum test using SPSS 19.0. The distribution and leakage of @entity4625 and complications ( @entity409 , dysneuria, etc.) were evaluated by CT and plain film. RESULTS: PVP in all @entity1 was successful. The preoperative mean value of VAS and the postoperative mean value of VAS showed statistical difference (8.4  1.4 and 3.1  2.3 respectively). At the end of follow-up, the mean value of VAS was 3.4  1.9. Bone cement leakage was observed in 35 vertebrae. Among the cases with bone cement leakage, one case showed the related complication (radiating @entity158 in left limb) and was relieved after treatment of @entity619 and analgesia for one week; the others did not present any related complication. CONCLUSION: With some limitations in the study, PVP appeared to be an alternative method to treat painful spine metastases.

Efficacy of percutaneous vertebroplasty in XXXX with painful vertebral metastases: A retrospective study in 47 cases.

@entity1 :: ('9606', 'Species') :: ['patients', 'PATIENTS'] @entity4625 :: ('MESH:D019904', 'Chemical') :: ['PMMA'] @entity5 :: ('MESH:D009369', 'Disease') :: ['metastatic tumours'] @entity409 :: ('MESH:D008107', 'Disease') :: ['cardiopulmonary dysfunction'] @entity619 :: ('MESH:D003907', 'Chemical') :: ['dexamethasone'] @entity158 :: ('MESH:D010146', 'Disease') :: ['Pain', 'pain']
@entity1 :: (9606,Species) :: ['patients']
